Drug interactions
Orphenadrin + Oxybutynin transdermal
Severity: Moderate
Orphenadrin and Oxybutynin transdermal: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs have antimuscarinic activity, and transdermal oxybutynin provides meaningful systemic levels. Combined use can cause dry mouth, constipation, urinary retention, blurred vision and confusion, particularly in older adults.
What this interaction means in plain words
Orphenadrin and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive antimuscarinic (anticholinergic) effects.
What to do
Monitor for anticholinergic toxicity, especially in elderly patients, and consider an alternative muscle relaxant or bladder agent if symptoms appear.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Orphenadrin and Oxybutynin transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Orphenadrin
Frequently asked questions
Can I take Orphenadrin with Oxybutynin transdermal?
MediHelp rates the interaction as moderate. Orphenadrin and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs have antimuscarinic activity, and transdermal oxybutynin provides meaningful systemic levels. Combined use can cause dry mouth, constipation, urinary retention, blurred vision and confusion, particularly in older adults.
How serious is the interaction between Orphenadrin and Oxybutynin transdermal?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic toxicity, especially in elderly patients, and consider an alternative muscle relaxant or bladder agent if symptoms appear.
What other medicines interact with Orphenadrin?
MediHelp also lists interactions of Orphenadrin with, for example, Alfentanil, Amobarbital, Benzhydrocodone / acetaminophen. The full list is on the Orphenadrin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
